Novartis Joins Harvard and Dana-Farber to Develop Delivery Systems for Immunotherapies – Immuno-Oncology News
Immuno-Oncology News |
Novartis Joins Harvard and Dana-Farber to Develop Delivery Systems for Immunotherapies
Immuno-Oncology News “We look forward to collaborating with the Wyss Institute to further develop this technology in conjunction with our growing immunotherapy portfolio.” A “cryogel” developed by Wyss and Dana-Farber researchers has been shown to benefit subsets of cancer … |
